Supply Chain Intelligence

Axsome Therapeutics, Inc. Supply Chain

AXSM supply chain intelligence for Axsome Therapeutics, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

AXSM ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

4Suppliers
3Customers
3Debt Items
20Related Chains

Axsome Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
JAZZ Jazz Pharmaceuticals plc 90% Pursuant to the Purchase Agreement, the Company agreed to make non-refundable, non-creditable royalty payments to Jazz
JAZZ Jazz Pharmaceuticals plc 90% Reciprocal relationship from JAZZ graph: Reciprocal relationship from AXSM graph: Reciprocal relationship from JAZZ graph: Reciprocal relationship from AXSM graph: Pursuant to the Purchase Agreement,…
AERIAL AERIAL 85% At the Initial Closing, the Company assumed all of the commitments of Jazz to SK and Aerial.
IGC IGC Pharma, Inc. 72% Reciprocal relationship from IGC graph: ing growth of the Life Sciences segment. These investments will fuel the development and delivery of innovative products that drive positive patient and custom…

Axsome Therapeutics, Inc. Customers

TickerNameConfidenceEvidence
PHARMANOVIA PHARMANOVIA 92% The Company also sells SUNOSI to Distributors in Canada and on a product supply basis to Pharmanovia.
IGC IGC Pharma, Inc. 72% Reciprocal relationship from IGC graph: Reciprocal relationship from AXSM graph: Reciprocal relationship from IGC graph: ing growth of the Life Sciences segment. These investments will fuel the devel…
XENE Xenon Pharmaceuticals Inc. 72% Reciprocal relationship from XENE graph: velopment and marketing efforts of our collaborators. • Our reliance on third parties to manufacture our product candidates may increase the risk that we will…

Axsome Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
AXSM-DEBT-8014 Warrants outstanding: 56.8 90% xbrl warrant detail from xbrl 2026-03-31.
AXSM-DEBT Debt stack $219.9M 90% Market cache reports total debt of $219.9M.
AXSM-DEBT-8015 Xbrl Convertible 90% xbrl convertible detail from xbrl 2016-12-31.

Axsome Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Axsome Therapeutics, Inc..

Axsome Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
AXSM-OWNER-BLACKROCK-INC BlackRock, Inc. 90% 13F overlay lists BlackRock, Inc. as top holder; 418 tracked holders.

Axsome Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ALEC Alector, Inc. 100.00 2
ACIU AC Immune SA 100.00 2
ALNY Alnylam Pharmaceuticals, Inc. 100.00 2
VNDA Vanda Pharmaceuticals Inc. 100.00 2
DAWN Day One Biopharmaceuticals Inc 100.00 2
BYSI BeyondSpring Inc. 100.00 2
CTNM Contineum Therapeutics, Inc. 100.00 2
SDGR Schrödinger, Inc. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
CLYM Climb Bio, Inc. 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
AKTS Aktis Oncology, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
DWTX Dogwood Therapeutics, Inc. 100.00 2
EDSA Edesa Biotech, Inc. 100.00 2
DFTX Definium Therapeutics, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
NVO Novo Nordisk A/S 100.00 2
FHTX Foghorn Therapeutics Inc. 100.00 2
ACRS Aclaris Therapeutics, Inc. 100.00 2
View AXSM supply chain intel →

Explore the full interactive supply chain map for Axsome Therapeutics, Inc..

Open AXSM supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map